e-learning
resources
Madrid 2019
Monday, 30.09.2019
Real-world experience of monoclonal antibodies in asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Self-administration of mepolizumab via an autoinjector: the patient experience
L. Evitt (London, United Kingdom), R. Follows (London, United Kingdom), J. Bentley (London, United Kingdom), W. Williams (Philadelphia, United States of America), R. Von Maltzahn (London, United Kingdom)
Source:
International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Session:
Real-world experience of monoclonal antibodies in asthma
Session type:
Thematic Poster
Number:
2522
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Evitt (London, United Kingdom), R. Follows (London, United Kingdom), J. Bentley (London, United Kingdom), W. Williams (Philadelphia, United States of America), R. Von Maltzahn (London, United Kingdom). Self-administration of mepolizumab via an autoinjector: the patient experience. 2522
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Mepolizumab self-administration via autoinjector and prefilled syringe: the qualitative patient experience
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019
Severe asthma and biologic therapies during COVID-19: supporting patients care with home administration of mepolizumab and omalizumab
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021
Inhaled medication: which device for which patient?
Source: Eur Respir Monogr 2015; 69: 213-223
Year: 2015
Gabapentin as add-on to fentanyl and midazolam in patients receiving mechanical ventilation: a randomized, blinded study
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2
Year: 2020
An electronic patient decision aid comparing as-needed budesonide-formoterol combination to regular use of inhaled corticosteroid (ICS) in mild asthma: a rapid-cycle design study
Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19
Year: 2021
Monitoring adherence to treatment regimen of inhaled medication use in a clinical trial with an investigational eFlow nebulizer (eTrack)
Source: International Congress 2017 – Medical education, web and internet
Year: 2017
Late Breaking Abstract - Cost effectiveness of as-needed budesonide/formoterol vs low-dose ICS maintenance therapy in mild asthma patients: A UK perspective
Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness
Year: 2019
Late Breaking Abstract - A randomized clinical study to assess the impact of budesonide/formoterol (BUD/FM) pMDI medication reminders on adherence in COPD patients
Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Year: 2018
The efficacy of the assistant use of short-acting β
2
stimulant procaterol on the daily activity in COPD patients. Niigata multicenter study
Source: Annual Congress 2011 - Bronchodilators in asthma and COPD
Year: 2011
The asthmatic patient and inhaler treatment devices profile in Turkey: Asthma inhaler treatment study
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012
Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study},
Source: Eur Respir J 2012; 40: 830-836
Year: 2012
Formoterol as relief medication in asthma: the jury is still out
Source: Eur Respir J 2003; 22: 723-724
Year: 2003
Efficacy, safety and acceptance of salbutamol administered via MAGhaler in children with mild to moderate asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 430s
Year: 2002
The use of high-dose inhaled corticosteroids and add-on therapy in children in the UK: an observational study of 4332 patients
Source: Annual Congress 2004 - New aspects of drug therapy in paediatric asthma
Year: 2004
1-year efficacy and safety study of tiotropium respimat add-on to ICS in adolescent patients with symptomatic asthma
Source: International Congress 2014 – Bronchodilators for asthma and COPD
Year: 2014
The Children's Anti-inflammatory Reliever (CARE) study: a protocol for a randomised controlled trial of budesonide-formoterol as sole reliever therapy in children with mild asthma
Source: ERJ Open Res, 7 (4) 00271-2021; 10.1183/23120541.00271-2021
Year: 2021
Survey of dyspnoea in COPD patients on medication and preemptive use of a short-acting β-2 agonist
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
COPD: Are beliefs about inhaled medication associated with patients’ inhaler technique?
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018
LATE-BREAKING ABSTRACT: A dose-ranging study of dupilumab in patients (pts) with uncontrolled asthma despite use of inhaled corticosteroids plus a long-acting beta-agonist (ICS/LABA): Final data
Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept